These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29958990)

  • 21. Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity.
    Bonatti R; Silva AF; Batatinha JA; Sobrado LF; Machado AD; Varone BB; Nearing BD; Belardinelli L; Verrier RL
    Heart Rhythm; 2014 Oct; 11(10):1827-35. PubMed ID: 24953379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy.
    Doki K; Homma M; Kuga K; Kawano S; Aonuma K; Yamaguchi I; Kohda Y
    J Clin Pharm Ther; 2007 Aug; 32(4):409-11. PubMed ID: 17635343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
    Beatch GN; Mangal B
    BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot study: Noninvasive monitoring of oral flecainide's effects on atrial electrophysiology during persistent human atrial fibrillation using the surface electrocardiogram.
    Husser D; Binias KH; Stridh M; Sornmo L; Olsson SB; Molling J; Geller C; Klein HU; Bollmann A
    Ann Noninvasive Electrocardiol; 2005 Apr; 10(2):206-10. PubMed ID: 15842433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.
    Capucci A; Piangerelli L; Ricciotti J; Gabrielli D; Guerra F
    Europace; 2016 Nov; 18(11):1698-1704. PubMed ID: 26893497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
    Boriani G; Biffi M; Capucci A; Botto G; Broffoni T; Ongari M; Trisolino G; Rubino I; Sanguinetti M; Branzi A; Magnani B
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2470-4. PubMed ID: 9825369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm.
    Borgeat A; Goy JJ; Maendly R; Kaufmann U; Grbic M; Sigwart U
    Am J Cardiol; 1986 Sep; 58(6):496-8. PubMed ID: 3529911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study on the acute conversion and maintenance of sinus rhythm in rheumatic atrial fibrillation using oral flecainide.
    Ghosh A; Kapoor A; Khanna R; Sahu A; Kumar S; Garg N; Tewari S; Goel P
    Indian Heart J; 2020; 72(5):383-388. PubMed ID: 33189198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial.
    Ruskin JN; Camm AJ; Dufton C; Woite-Silva AC; Tuininga Y; Badings E; De Jong JSSG; Oosterhof T; Aksoy I; Kuijper AFM; Van Gelder IC; van Dijk V; Nuyens D; Schellings D; Lee MY; Kowey PR; Crijns HJGM; Maupas J; Belardinelli L;
    JACC Clin Electrophysiol; 2024 Jun; 10(6):1021-1033. PubMed ID: 38613545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.
    Vereckei A; Gorski JC; Ujhelyi M; Mehra R; Zipes DP
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):269-77. PubMed ID: 15367824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.
    Yamamoto W; Hashimoto N; Matsuura J; Machida T; Ogino Y; Kobayashi T; Yamanaka Y; Ishiwata N; Yamashita T; Tanimoto K; Miyoshi S; Fukuda K; Nakaya H; Ogawa S
    J Cardiovasc Pharmacol; 2014 May; 63(5):421-7. PubMed ID: 24805146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in organization index predicts atrial fibrillation termination with flecainide post-ablation: spectral analysis of intracardiac electrograms.
    Tuan J; Osman F; Jeilan M; Kundu S; Mantravadi R; Stafford PJ; Ng GA
    Europace; 2010 Apr; 12(4):488-93. PubMed ID: 20022876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
    Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L
    Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses.
    Haugaard MM; Pehrson S; Carstensen H; Flethøj M; Hesselkilde EZ; Praestegaard KF; Diness JG; Grunnet M; Jespersen T; Buhl R
    J Vet Intern Med; 2015 Jan; 29(1):339-47. PubMed ID: 25328012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room].
    Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T
    Harefuah; 2006 May; 145(5):342-4, 398. PubMed ID: 16805213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
    Balla I; Petrela E; Kondili A
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation.
    Wang Z; Pagé P; Nattel S
    Circ Res; 1992 Aug; 71(2):271-87. PubMed ID: 1628386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.